BRIEF published on 06/19/2024 at 18:05, 1 year 8 months ago Xironetic Appoints Jeff Potts to Chief Technology Officer Chief Technology Officer Augmented Reality Xironetic Jeff Potts Surgical Guidance Technology
BRIEF published on 06/19/2024 at 18:05, 1 year 8 months ago Xironetic nomme Jeff Potts au poste de directeur de la technologie Réalité Augmentée Directeur De La Technologie Jeff Potts Xironétique Technologie De Guidage Chirurgical
PRESS RELEASE published on 06/19/2024 at 18:00, 1 year 8 months ago Xironetic Appoints Jeff Potts to Chief Technology Officer Xironetic appoints Jeff Potts as Chief Technology Officer, recognizing his crucial role in product development and company growth. Xironetic focuses on AR surgical guidance technology Chief Technology Officer Augmented Reality Xironetic Jeff Potts Surgical Guidance
Published on 02/20/2026 at 18:30, 13 minutes ago Sparta Updates Delay in Filing Annual Financial Statements
Published on 02/20/2026 at 15:45, 2 hours 58 minutes ago Revolve Announces Closing of Initial US$10 Million Advance on Strategic Financing With Callaway
Published on 02/20/2026 at 14:30, 4 hours 13 minutes ago Norse Gold Announces Application for Reactivation to TSX-V, Private Placement Financing and Stock Options Grant
Published on 02/20/2026 at 14:08, 4 hours 35 minutes ago Datavault AI Announces Anticipated Launch of Josh Gibson Stablecoin and Josh Gibson NIL Strategies for Its Forthcoming NIL Exchange
Published on 02/20/2026 at 14:00, 4 hours 43 minutes ago Nextech3D.ai's Eventdex Platform Powers AI Matchmaking for the SBA's CT Business Matchmaker Event Featuring Government Agencies and Major Prime Contractors
Published on 02/20/2026 at 18:36, 7 minutes ago EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Published on 02/20/2026 at 18:31, 12 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/20/2026 at 18:00, 43 minutes ago Leclanché conclut un accord de financement d’un montant de CHF 16,7 millions pour soutenir ses opérations à court terme
Published on 02/20/2026 at 18:00, 43 minutes ago Leclanché Secures Financing Arrangement in the amount of CHF 16.7 million to Support Near-Term Operations
Published on 02/20/2026 at 09:28, 9 hours 15 minutes ago Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 31 janvier 2026
Published on 02/20/2026 at 09:28, 9 hours 15 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of January 31, 2026
